D. E. Shaw & Co., Inc. Eli Lilly & CO Transaction History
D. E. Shaw & Co., Inc.
- $156 Billion
- Q3 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 488,630 shares of LLY stock, worth $501 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
488,630
Previous 528,132
7.48%
Holding current value
$501 Million
Previous $412 Million
9.44%
% of portfolio
0.24%
Previous 0.33%
Shares
32 transactions
Others Institutions Holding LLY
# of Institutions
4,499Shares Held
754MCall Options Held
15.9MPut Options Held
15.3M-
Lilly Endowment Inc Indianapolis, IN95.5MShares$97.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA81MShares$83 Billion0.96% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$67.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$52.7 Billion24.16% of portfolio
-
State Street Corp Boston, MA34.7MShares$35.6 Billion0.95% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $974B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...